Finsbury Worldwide Pharmaceutical Trust
(Public, LON:FWP) Watch this stockFind more results forFWP
Events
Sep 4, 2009
FINSBURY WORLDWIDE PHARMACEUTL General Meeting
|
|
Key stats and ratios
| Q1 (Mar '09) | 2009 | |
| Net profit margin | 729.04% | 1599.38% |
| Operating margin | 23.20% | 7.62% |
| EBITD margin | - | - |
| Return on average assets | 13.23% | 23.00% |
| Return on average equity | 15.78% | 26.35% |
Address
25 Southampton Buildings
London, ENG WC2A 1AL
United Kingdom - Map
+44-203-0084910 (Phone)
+44-203-0438889 (Fax)
London, ENG WC2A 1AL
United Kingdom - Map
+44-203-0084910 (Phone)
+44-203-0438889 (Fax)
Website links
External links
Analyst Estimates - BusinessWeek
Options - MarketWatch
Research Reports - Reuters
Director Dealings - Yahoo Finance
Finsbury Worldwide Pharmaceutical Trust discussions
View all discussions »Description
Finsbury Worldwide Pharmaceutical Trust PLC is an investment trust. The Company invests worldwide in pharmaceutical and biotechnology companies with the objective of achieving capital growth. Management, administrative, secretarial and other services are provided to the Company by Frostrow Capital LLP (the Manager). As at March 31, 2009, the Company's top 10-investment portfolio were Tepnel Life Sciencea, Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline, Wyeth, Amgen, Biogen Idec, Vertex Pharmaceuticals and Genzyme.